Merck is testing a single dose of Gardasil 9 HPV vaccine

Merck & Co said on Wednesday it plans to conduct a clinical trial of its human papillomavirus (HPV) vaccine Gardasil 9 to evaluate the efficacy and safety of a single-dose regimen compared to an approved three-dose regimen.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM